Act Before 11:59pm: Last Day to SAVE 80% on Our Midcap Stocks Research
Here is the latest financial fact sheet of WINDLAS BIOTECH. For more details, see the WINDLAS BIOTECH quarterly results and WINDLAS BIOTECH share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -2.8 |
No. of shares | m | 20.80 |
1 Week | % | 4.9 |
1 Month | % | 4.0 |
1 Year | % | 119.2 |
52 week H/L | Rs | 590.0/249.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
WINDLAS BIOTECH EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | 452 | 280 | |
Low | Rs | NA | NA | NA | 209 | 203 | |
Sales per share (Unadj.) | Rs | 479.4 | 513.0 | 667.1 | 213.8 | 245.1 | |
Earnings per share (Unadj.) | Rs | 99.6 | 25.3 | 24.3 | 17.5 | 20.4 | |
Diluted earnings per share | Rs | 30.7 | 7.8 | 7.5 | 18.3 | 20.5 | |
Cash flow per share (Unadj.) | Rs | 116.1 | 39.8 | 44.5 | 23.1 | 26.3 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 3.50 | 4.00 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 3.67 | 4.03 | |
Avg Dividend yield | % | 0 | 0 | 0 | 1.1 | 1.7 | |
Book value per share (Unadj.) | Rs | 302.0 | 327.1 | 310.6 | 180.3 | 190.9 | |
Adj. book value per share | Rs | 93.1 | 100.8 | 95.7 | 188.9 | 192.1 | |
Shares outstanding (eoy) | m | 6.41 | 6.41 | 6.41 | 21.79 | 20.93 | |
Price / Sales ratio | x | 0 | 0 | 0 | 1.5 | 1.0 | |
Avg P/E ratio | x | 0 | 0 | 0 | 18.9 | 11.9 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 14.3 | 9.2 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 1.8 | 1.3 | |
Dividend payout | % | 0 | 0 | 0 | 20.0 | 19.6 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 7,203 | 5,055 | |
Total wages/salary | Rs m | 430 | 436 | 583 | 634 | 703 |
WINDLAS BIOTECH INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 3,073 | 3,289 | 4,276 | 4,659 | 5,131 | |
Other income | Rs m | 43 | 25 | 31 | 67 | 100 | |
Total revenues | Rs m | 3,115 | 3,313 | 4,307 | 4,726 | 5,230 | |
Gross profit | Rs m | 873 | 340 | 329 | 524 | 602 | |
Depreciation | Rs m | 106 | 93 | 130 | 121 | 124 | |
Interest | Rs m | 48 | 25 | 13 | 14 | 8 | |
Profit before tax | Rs m | 761 | 247 | 217 | 456 | 570 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 123 | 85 | 62 | 75 | 144 | |
Profit after tax | Rs m | 638 | 162 | 156 | 381 | 426 | |
Gross profit margin | % | 28.4 | 10.3 | 7.7 | 11.3 | 11.7 | |
Effective tax rate | % | 16.2 | 34.3 | 28.4 | 16.4 | 25.3 | |
Net profit margin | % | 20.8 | 4.9 | 3.6 | 8.2 | 8.3 |
WINDLAS BIOTECH BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,205 | 1,680 | 1,943 | 3,817 | 3,535 | |
Current liabilities | Rs m | 962 | 1,253 | 934 | 940 | 1,212 | |
Net working cap to sales | % | 7.9 | 13.0 | 23.6 | 61.7 | 45.3 | |
Current ratio | x | 1.3 | 1.3 | 2.1 | 4.1 | 2.9 | |
Inventory Days | Days | 154 | 135 | 25 | 57 | 111 | |
Debtors Days | Days | 73 | 71 | 68 | 87 | 83 | |
Net fixed assets | Rs m | 1,772 | 1,698 | 1,018 | 1,073 | 1,734 | |
Share capital | Rs m | 64 | 64 | 64 | 109 | 105 | |
"Free" reserves | Rs m | 1,872 | 2,032 | 1,927 | 3,821 | 3,890 | |
Net worth | Rs m | 1,936 | 2,097 | 1,991 | 3,930 | 3,995 | |
Long term debt | Rs m | 58 | 12 | 8 | 4 | 1 | |
Total assets | Rs m | 2,977 | 3,378 | 2,961 | 4,890 | 5,270 | |
Interest coverage | x | 16.7 | 10.8 | 17.9 | 33.2 | 73.4 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.0 | 1.0 | 1.4 | 1.0 | 1.0 | |
Return on assets | % | 23.1 | 5.5 | 5.7 | 8.1 | 8.2 | |
Return on equity | % | 33.0 | 7.7 | 7.8 | 9.7 | 10.7 | |
Return on capital | % | 40.6 | 12.9 | 11.5 | 11.9 | 14.5 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 63 | 0 | 1 | 232 | 218 | |
Fx outflow | Rs m | 11 | 0 | 0 | 61 | 68 | |
Net fx | Rs m | 52 | 0 | 1 | 171 | 150 |
WINDLAS BIOTECH CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 187 | 250 | 115 | 91 | 610 | |
From Investments | Rs m | -53 | -143 | -202 | -1,546 | -141 | |
From Financial Activity | Rs m | -62 | -54 | 8 | 1,301 | -437 | |
Net Cashflow | Rs m | 57 | 52 | -21 | -154 | 31 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Vivek Dhariwal | COMP SEC: Ananta Narayan Panda | YEAR OF INC: 2001 | BSE CODE: 543329 | FV (Rs): 5 | DIV YIELD (%): 0.7 |
Read: WINDLAS BIOTECH 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare WINDLAS BIOTECH With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.